ANDA 40191, held by Strides Pharma Intl. Meperidine Hydrochloride.
As of Nov 16, 2026, ANDA 40191 (Meperidine Hydrochloride), held by Strides Pharma Intl, was first approved by FDA on Dec 17, 1998, with 15 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 17, 1998 | Original application | Approved |
| Meperidine Hydrochloride50MG · tablet;oral | Meperidine Hydrochloride | Discontinued |
| Meperidine Hydrochloride100MG · tablet;oral | Meperidine Hydrochloride | Discontinued |
| Jun 18, 2026 | Supplement 23REMS | Approved | None posted |
| May 15, 2026 | Supplement 22Labeling · Standard review | Approved | None posted |
| Dec 22, 2025 | Supplement 21Labeling · Standard review | Approved | None posted |
| Oct 31, 2024 | Supplement 20REMS | Approved | None posted |
| Jul 15, 2024 | Supplement 19Labeling · Standard review | Approved | None posted |
| Dec 15, 2023 | Supplement 18Labeling · Standard review | Approved | None posted |
| Dec 15, 2023 | Supplement 17Labeling · Standard review | Approved | None posted |
| Dec 13, 2023 | Supplement 16Labeling · Standard review | Approved | None posted |
| Dec 13, 2023 | Supplement 13Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 14REMS · Standard review | Approved | None posted |
| Jan 6, 2015 | Supplement 8Labeling | Approved | None posted |
| Oct 18, 2011 | Supplement 6Labeling | Approved | None posted |
| Jul 1, 2009 | Supplement 5Labeling | Approved | None posted |
| Oct 6, 2005 | Supplement 4Labeling | Approved | None posted |
| Jul 7, 2005 | Supplement 3Labeling | Approved | None posted |
| Dec 17, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters